News
Ponvory Now Available for Relapsing Forms of Multiple Sclerosis
Ponvory is a once-daily oral selective sphingosine-1-phosphate receptor 1 modulator.
Significant reduction found in risk for disease progression/death for C+R versus placebo and rituximab
Increased exposure linked to significantly increased rates of incident keratinocyte carcinoma, melanoma in adults ≥66 years